{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T18:38:48Z","timestamp":1773772728947,"version":"3.50.1"},"reference-count":58,"publisher":"Pleiades Publishing Ltd","issue":"1","license":[{"start":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T00:00:00Z","timestamp":1720828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T00:00:00Z","timestamp":1720828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dokl Biochem Biophys"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1134\/s1607672924700984","type":"journal-article","created":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T10:02:02Z","timestamp":1720864922000},"page":"250-258","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical Manifestations and Prognosis of Giant Cell Arteritis: A Retrospective Cohort Study"],"prefix":"10.1134","volume":"517","author":[{"given":"E. E.","family":"Fedorinova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. M.","family":"Bulanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. D.","family":"Meshkov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O. O.","family":"Borodin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. O.","family":"Smitienko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. V.","family":"Chachilo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. A.","family":"Nartov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. L.","family":"Filatova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. V.","family":"Naumov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. I.","family":"Novikov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. V.","family":"Moiseev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"137","published-online":{"date-parts":[[2024,7,13]]},"reference":[{"key":"7541_CR1","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1001\/jama.2016.5444","volume":"315","author":"F. Buttgereit","year":"2016","unstructured":"Buttgereit, F., Dejaco, Ch., Matteson, E.L., and Dasgupta, B., Polymyalgia rheumatica and giant cell arteritis: a systematic review, JAMA, 2016, vol. 315, no.\u00a022, pp. 2442\u20132458. https:\/\/doi.org\/10.1001\/jama.2016.5444","journal-title":"JAMA"},{"key":"7541_CR2","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1056\/nejmra022694","volume":"349","author":"C.M. Weyand","year":"2003","unstructured":"Weyand, C.M. and Goronzy, J.J., Medium- and large-vessel vasculitis, N. Engl. J. Med., 2003, vol. 349, no. 2, pp. 160\u2013169. https:\/\/doi.org\/10.1056\/nejmra022694","journal-title":"N. Engl. J. Med."},{"key":"7541_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1056\/nejmcp1214825","volume":"371","author":"C.M. Weyand","year":"2014","unstructured":"Weyand, C.M. and Goronzy, J.J., Giant-cell arteritis and polymyalgia rheumatica, N. Engl. J. Med., 2014, vol. 371, no. 1, pp. 50\u201357. https:\/\/doi.org\/10.1056\/nejmcp1214825","journal-title":"N. Engl. J. Med."},{"key":"7541_CR4","first-page":"48","volume":"23","author":"A.D. Meshkov","year":"2014","unstructured":"Meshkov, A.D., Novikov, P.I., Fomin, V.V., and Moiseev, S.V., Giant cell arteritis: diagnostic and treatment, Klin. Farmakol. Ter., 2014, vol. 23, no. 2, pp. 48\u201354.","journal-title":"Klin. Farmakol. Ter."},{"key":"7541_CR5","doi-asserted-by":"publisher","unstructured":"Satybaldyev, A.M., Giant cell arteritis. Part I. Terminology, classification, clinical manifestations, diagnosis, Sovrem. Revmatol., 2012, no. 3, pp. 23\u201327. https:\/\/doi.org\/10.14412\/1996-7012-2012-741","DOI":"10.14412\/1996-7012-2012-741"},{"key":"7541_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jaut.2014.01.017","volume":"48\u201349","author":"G. Nesher","year":"2014","unstructured":"Nesher, G., The diagnosis and classification of giant cell arteritis, J. Autoimmun., 2014, vols. 48\u201349, pp. 73\u201375. https:\/\/doi.org\/10.1016\/j.jaut.2014.01.017","journal-title":"J. Autoimmun."},{"key":"7541_CR7","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/art.30155","volume":"63","author":"C.S. Crowson","year":"2011","unstructured":"Crowson, C.S., Matteson, E.L., Myasoedova, E., Michet, C.J., Ernste, F.C., Warrington, K.J., Davis, J.M., Hunder, G.G., Therneau, T.M., and Gabriel, Sh.E., The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases, Arthritis Rheum., 2011, vol. 63, no. 3, pp. 633\u2013639. https:\/\/doi.org\/10.1002\/art.30155","journal-title":"Arthritis Rheum."},{"key":"7541_CR8","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1093\/rheumatology\/kew273","volume":"56","author":"C. Dejaco","year":"2017","unstructured":"Dejaco, C., Duftner, C., Buttgereit, F., Matteson, E.L., and Dasgupta, B., The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease, Rheumatology, 2017, vol. 56, no. 4, pp.\u00a0506\u2013515. https:\/\/doi.org\/10.1093\/rheumatology\/kew273","journal-title":"Rheumatology"},{"key":"7541_CR9","first-page":"1484","volume":"21","author":"R.D. Wigley","year":"1994","unstructured":"Wigley, R.D., Zhang, N.Z., Zeng, Q.Y., Shi, C.-S., and Hu, D.W., Rheumatic diseases in China: ILAR-China study comparing the prevalence of rheumatic symptoms in northern and southern rural populations, J. Rheumatol., 1994, vol. 21, no. 8, pp. 1484\u20131490.","journal-title":"J. Rheumatol."},{"key":"7541_CR10","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1002\/art.1780261007","volume":"26","author":"C.A. Smith","year":"1983","unstructured":"Smith, C.A., Fidler, W.J., and Pinals, R.S., The epidemiology of giant cell arteritis. Report of a Ten-Year Study in Shelby County, Tennessee, Arthritis Rheum., 1983, vol. 26, no. 10, pp. 1214\u20131219. https:\/\/doi.org\/10.1002\/art.1780261007","journal-title":"Arthritis Rheum."},{"key":"7541_CR11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.18565\/therapy.2023.1.78-88","volume":"1","author":"A.D. Meshkov","year":"2023","unstructured":"Meshkov, A.D., Maslyansky, A.L., Tkacheva, O.N., and Mazurov, V.I., Treatment of giant cell arteritis: current possibilities and prospects of steroid-sparing therapy, Terapiya, 2023, vol. 1, no. 9, pp. 78\u201388. https:\/\/doi.org\/10.18565\/therapy.2023.1.78-88","journal-title":"Terapiya"},{"key":"7541_CR12","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/s0161-6420(93)31608-8","volume":"100","author":"P.D. Aiello","year":"1993","unstructured":"Aiello, P.D., Trautmann, J.C., McPhee, T.J., Kunselman, A.R., and Hunder, G.G., Visual prognosis in giant cell arteritis, Ophthalmology, 1993, vol. 100, no. 4, pp. 550\u2013555. https:\/\/doi.org\/10.1016\/s0161-6420(93)31608-8","journal-title":"Ophthalmology"},{"key":"7541_CR13","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/wno.0b013e318268aa9b","volume":"32","author":"C.M. Weyand","year":"2012","unstructured":"Weyand, C.M., Liao, Y.J., and Goronzy, J.J., The immunopathology of giant cell arteritis: diagnostic and therapeutic implications, J. Neuro-Ophthalmol., 2012, vol. 32, no. 3, pp. 259\u2013265. https:\/\/doi.org\/10.1097\/wno.0b013e318268aa9b","journal-title":"J. Neuro-Ophthalmol."},{"key":"7541_CR14","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/rheumatology\/kex397","volume":"57","author":"T.A. Kermani","year":"2018","unstructured":"Kermani, T.A., Sreih, A.G., Cuthbertson, D., Carette, S., Hoffman, G.S., Khalidi, N.A., Koening, C.L., Langford, C.A., Mcalear, C.A., Monach, P.A., Moreland, L., Pagnoux, Ch., Seo, P., Warrington, K.J., Ytterberg, S.R., and Merkel, P.A., Evaluation of damage in giant cell arteritis, Rheumatology, 2018, vol. 57, no. 2, pp. 322\u2013328. https:\/\/doi.org\/10.1093\/rheumatology\/kex397","journal-title":"Rheumatology"},{"key":"7541_CR15","first-page":"79","volume":"24","author":"N.A. Mukhin","year":"2015","unstructured":"Mukhin, N.A., Meshkov, A.D., Novikov, P.I., Moiseev, S.V., Scherbakova, V.D., et al., Giant cell arteritis: clinical manifestations and methods of early diagnosis, Klin. Farmakol. Ter., 2015, vol. 24, no. 3, pp. 79\u201385.","journal-title":"Klin. Farmakol. Ter."},{"key":"7541_CR16","doi-asserted-by":"crossref","unstructured":"De Boysson, H., Liozon, E., Ly, K.H., Dumont, A., Delmas, C., and Aouba, A., The different clinical patterns of giant cell arteritis, Clin. Exp. Rheumatol., 2019, vol. 37, no. suppl. 117, pp. 57\u201360.","DOI":"10.1007\/s10067-018-4244-6"},{"key":"7541_CR17","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4997\/jrcpe.2017.203","volume":"47","author":"S. Gajree","year":"2017","unstructured":"Gajree, S., Borooah, S., Dhillon, N., Goudie, C., Smith, C., Aspinall, P., and Dhillon, B., Temporal artery biopsies in south-east Scotland: a five year review, J. R. Coll. Physicians Edinb., 2017, vol. 47, no. 2, pp.\u00a0124\u2013128. https:\/\/doi.org\/10.4997\/jrcpe.2017.203","journal-title":"J. R. Coll. Physicians Edinb."},{"key":"7541_CR18","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10157-013-0869-6","volume":"17","author":"J.C. Jennette","year":"2013","unstructured":"Jennette, J.C., Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides, Clin. Exp. Nephrol., 2013, vol. 17, no. 5, pp. 603\u2013606. https:\/\/doi.org\/10.1007\/s10157-013-0869-6","journal-title":"Clin. Exp. Nephrol."},{"key":"7541_CR19","first-page":"70","volume":"22","author":"P.I. Novikov","year":"2013","unstructured":"Novikov, P.I., Semenkova, E.N., and Moiseev, S.V., Modern nomenclature of systemic vasculitis, Klin. Farmakol. Ter., 2013, vol. 22, no. 1, pp. 70\u201374.","journal-title":"Klin. Farmakol. Ter."},{"key":"7541_CR20","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1136\/annrheumdis-2012-202408","volume":"72","author":"T.A. Kermani","year":"2013","unstructured":"Kermani, T.A., Warrington, K.J., Crowson, C.S., Ytterberg, S.R., Hunder, G.G., Gabriel, Sh.E., and Matteson, E.L., Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis, Ann. Rheum. Dis., 2013, vol. 72, no. 12, pp. 1989\u20131994. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202408","journal-title":"Ann. Rheum. Dis."},{"key":"7541_CR21","first-page":"210","volume":"38","author":"G.S. Breuer","year":"2020","unstructured":"Breuer, G.S., Poltorak, V., and Nesher, G., Survival of patients with giant cell arteritis: a controversial issue, Clin. Exp. Rheumatol., 2020, vol. 38, suppl. 124, pp.\u00a0210\u2013213.","journal-title":"Clin. Exp. Rheumatol."},{"key":"7541_CR22","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1002\/art.39596","volume":"68","author":"J. Schmidt","year":"2016","unstructured":"Schmidt, J., Smail, A., Roche, B., Gay, P., Salle, V., Pellet, H., and Duhaut, P., Incidence of severe infections and infection-related mortality during the course of giant cell arteritis: a multicenter, prospective, double-cohort study, Arthritis Rheumatol., 2016, vol. 68, no. 6, pp. 1477\u20131482. https:\/\/doi.org\/10.1002\/art.39596","journal-title":"Arthritis Rheumatol."},{"key":"7541_CR23","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1093\/rheumatology\/keu433","volume":"54","author":"S.P. Mollan","year":"2015","unstructured":"Mollan, S.P., Begaj, I., Mackie, S., O\u2019sullivan, E.P., and Denniston, A.K., Increase in admissions related to giant cell arteritis and polymyalgia rheumatica in the UK, 2002-13, without a decrease in associated sight loss: potential implications for service provision, Rheumatology, 2015, vol. 54, no. 2, pp. 375\u2013377. https:\/\/doi.org\/10.1093\/rheumatology\/keu433","journal-title":"Rheumatology"},{"key":"7541_CR24","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/art.1780330810","volume":"33","author":"G.G. Hunder","year":"1990","unstructured":"Hunder, G.G., Bloch, D.A., Michel, B.A., Stevens,\u00a0M.B., Arend, W.P., Calabrese, L.H., Edworthy,\u00a0S.M., Fauci, A.S., Leavitt, R.Y., Lie, J.T., Lightfoot, R.W., Masi, A.T., Mcshane, D.J., Mills, J.A., Wallace, S.L., and Zvaifler, N.J., The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis, Arthritis Rheum., 1990, vol.\u00a033, no. 8, pp. 1122\u20131128. https:\/\/doi.org\/10.1002\/art.1780330810","journal-title":"Arthritis Rheum."},{"key":"7541_CR25","first-page":"1","volume":"3","author":"I. Salehi-Abari","year":"2016","unstructured":"Salehi-Abari, I., 2016 ACR revised criteria for early diagnosis of giant cell (temporal) arteritis, Autoimmune Dis. Ther. Approaches Open Access, 2016, vol. 3, pp. 1\u20134.","journal-title":"Autoimmune Dis. Ther. Approaches Open Access"},{"key":"7541_CR26","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1136\/ard-2022-223480","volume":"81","author":"C. Ponte","year":"2022","unstructured":"Ponte, C., Grayson, P.C., Robson, J.C., Suppiah, R., Gribbons, K.B., Judge, A., Craven, A., Khalid, S., Hutchings, A., Watts, R.A., Merkel, P.A., and Luqmani, R.A., 2022 American College of Rheumatology\/EULAR classification criteria for giant cell arteritis, Ann. Rheum. Dis., 2022, vol. 81, no. 12, pp. 1647\u20131653. https:\/\/doi.org\/10.1136\/ard-2022-223480","journal-title":"Ann. Rheum. Dis."},{"key":"7541_CR27","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/art.34356","volume":"64","author":"B. Dasgupta","year":"2012","unstructured":"Dasgupta, B., Cimmino, M.A., Kremers, H.M., Schmidt, W.A., Schirmer, M., and Salvarani, C., Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative, Arthritis Rheum., 2012, vol. 64, no. 4, pp. 943\u2013954. https:\/\/doi.org\/10.1002\/art.34356","journal-title":"Arthritis Rheum."},{"key":"7541_CR28","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1136\/bmj.317.7172.1572","volume":"317","author":"J.M. Bland","year":"1998","unstructured":"Bland, J.M. and Altman, D.G., Statistics notes: survival probabilities (the Kaplan-Meier method), BMJ, 1998, vol. 317, no. 7172, pp. 1572\u20131580. https:\/\/doi.org\/10.1136\/bmj.317.7172.1572","journal-title":"BMJ"},{"key":"7541_CR29","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3899\/jrheum.220860","volume":"50","author":"K. Majerovich","year":"2023","unstructured":"Majerovich, K., Junek, M., Khalidi, N., and Garner, S., Duration of steroid therapy and temporal artery biopsy positivity in giant cell arteritis: a retrospective cohort study, J. Rheumatol., 2023, vol. 50, no. 7, pp. 965\u2013966. https:\/\/doi.org\/10.3899\/jrheum.220860","journal-title":"J. Rheumatol."},{"key":"7541_CR30","series-title":"Giant cell arteritis: current advances in pathogenesis and treatment","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.91018","volume-title":"Vascular Biology\u2014Selection of Mechanisms and Clinical Applications","author":"M.A. Dagostin","year":"2020","unstructured":"Dagostin, M.A. and Pereira, R.M.R., Giant cell arteritis: current advances in pathogenesis and treatment, in Vascular Biology\u2014Selection of Mechanisms and Clinical Applications, Gonz\u00e1lez, M., Ed., Rijeka: IntechOpen, 2020, ch. 6. https:\/\/doi.org\/10.5772\/intechopen.91018"},{"key":"7541_CR31","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/s0140-6736(12)60680-1","volume":"381","author":"T.A. Kermani","year":"2013","unstructured":"Kermani, T.A. and Warrington, K.J., Polymyalgia rheumatica, Lancet, 2013, vol. 381, no. 9860, pp. 63\u201372. https:\/\/doi.org\/10.1016\/s0140-6736(12)60680-1","journal-title":"Lancet"},{"key":"7541_CR32","unstructured":"Patil, P., Williams, M., Maw, W.W., Achilleos, K., Elsideeg, S., and Dejaco, C., Fast track pathway reduces sight loss in giant cell arteritis: results of a longitudinal observational cohort study, Clin. Exp. Rheumatol., 2015, vol. 33, no. suppl 2, pp. 103\u2013106."},{"key":"7541_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0002-9343(90)90121-S","volume":"88","author":"J.P. Ninet","year":"1990","unstructured":"Ninet, J.P., Bachet, P., Dumontet, C.M., Colombier, D., Stewart, P.B., Pasquier, M.D., and H, J., Subclavian and axillary involvement in temporal arteritis and polymyalgia rheumatica, Am. J. Med., 1990, vol. 88, no.\u00a01, pp. 13\u201320.","journal-title":"Am. J. Med."},{"key":"7541_CR34","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.autrev.2014.12.005","volume":"14","author":"A. Berti","year":"2015","unstructured":"Berti, A., Campochiaro, C., Cavalli, G., Pepe, G., Praderio, L., Sabbadini, M.G., and Dagna, L., Giant cell arteritis restricted to the limb arteries: an overlooked clinical entity, Autoimmun. Rev., 2015, vol. 14, no. 4, pp.\u00a0352\u2013357. https:\/\/doi.org\/10.1016\/j.autrev.2014.12.005","journal-title":"Autoimmun. Rev."},{"key":"7541_CR35","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/md.0000000000000033","volume":"93","author":"M.A. Alba","year":"2014","unstructured":"Alba, M.A., Garc\u00eda-Mart\u00ednez, A., Prieto-Gonz\u00e1lez, S., Tavera-Bahillo, I., Corbera-Bellalta, M., Planas-Rigol, E., Esp\u00edgol-Frigol\u00e9, G., Butjosa, M., Hern\u00e1ndez-Rodr\u00edguez, J., and Cid, M.C., Relapses in patients with giant cell arteritis: prevalence, characteristics, and associated clinical findings in a longitudinally followed cohort of 106 patients, Medicine (Baltimore), 2014, vol.\u00a093, no. 5, pp. 194\u2013201. https:\/\/doi.org\/10.1097\/md.0000000000000033","journal-title":"Medicine (Baltimore)"},{"key":"7541_CR36","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.ajo.2012.03.045","volume":"154","author":"A.P. Murchison","year":"2012","unstructured":"Murchison, A.P., Gilbert, M.E., Bilyk, J.R., Eagle, R.C., Pueyo, V., Sergott, R.C., and Savino, P.J., Validity of the American College of Rheumatology criteria for the diagnosis of giant cell arteritis, Am. J. Ophthalmol., 2012, vol. 154, no. 4, pp. 722\u2013729. https:\/\/doi.org\/10.1016\/j.ajo.2012.03.045","journal-title":"Am. J. Ophthalmol."},{"key":"7541_CR37","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1093\/rheumatology\/keq039a","volume":"49","author":"B. Dasgupta","year":"2010","unstructured":"Dasgupta, B., Borg, F.A., Hassan, N., Alexander, L., Barraclough, K., Bourke, B., Fulcher, J., Hollywood, J., Hutchings, A., James, P., Kyle, V., Nott, J., Power, M., and Samanta, A., BSR and BHPR guidelines for the management of giant cell arteritis, Rheumatology, 2010, vol. 49, no. 8, pp. 1594\u20131597. https:\/\/doi.org\/10.1093\/rheumatology\/keq039a","journal-title":"Rheumatology"},{"key":"7541_CR38","doi-asserted-by":"publisher","unstructured":"Moiseev, S.V., Smitienko, I., Bulanov, N., and Novikov, P.I., The role of temporal artery biopsy in patients with giant-cell arteritis is debated, Ann. Rheumatic Dis., 2019, vol. 78, no. 4, p. e31. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213282","DOI":"10.1136\/annrheumdis-2018-213282"},{"key":"7541_CR39","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1093\/rheumatology\/kex143","volume":"56","author":"V.S. Sch\u00e4fer","year":"2017","unstructured":"Sch\u00e4fer, V.S., Juche, A., Ramiro, S., Krause, A., and Schmidt, W.A., Ultrasound cut-off values for intima-media thickness of temporal, facial and axillary arteries in giant cell arteritis, Rheumatology, 2017, vol. 56, no. 9, pp. 1479\u20131483. https:\/\/doi.org\/10.1093\/rheumatology\/kex143","journal-title":"Rheumatology"},{"key":"7541_CR40","doi-asserted-by":"publisher","first-page":"106","DOI":"10.47360\/1995-4484-2023-106-111","volume":"61","author":"E.E. Filatova","year":"2023","unstructured":"Filatova, E.E., Bulanov, N.M., Meshkov, A.D., Borodin, O.O., Smitienko, I.O., Chachilo, E.V., Novikov,\u00a0P.I., and Moiseev, S.V., Damage to extracranial arteries in giant cell arteritis according to PET\/CT, Nauchno-Prakt. \n               Revmatol., 2023, vol. 61, no. 1, pp.\u00a0106\u2013111. https:\/\/doi.org\/10.47360\/1995-4484-2023-106-111","journal-title":"Revmatol."},{"key":"7541_CR41","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1093\/rheumatology\/kex376","volume":"57","author":"L. Henckaerts","year":"2018","unstructured":"Henckaerts, L., Gheysens, O., Vanderschueren, S., Goffin, K., and Blockmans, D., Use of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis of polymyalgia rheumatica\u2014a prospective study of 99 patients, Rheumatology, 2018, vol. 57, no. 11, pp.\u00a01908\u20131916. https:\/\/doi.org\/10.1093\/rheumatology\/kex376","journal-title":"Rheumatology"},{"key":"7541_CR42","doi-asserted-by":"publisher","unstructured":"De Boysson, H., Lambert, M., Liozon, E., Boutemy, J., Maign\u00e9, G., Ollivier, Ya., Ly, K., Manrique, A., Bienvenu, B., and Aouba, A., Giant-cell arteritis without cranial manifestations, Medicine (Baltimore), 2016, vol.\u00a095, no. 26, p. e3818. https:\/\/doi.org\/10.1097\/md.0000000000003818","DOI":"10.1097\/md.0000000000003818"},{"key":"7541_CR43","doi-asserted-by":"publisher","unstructured":"Malich, L., G\u00fchne, F., Hoffmann, T., Malich, A., Weise, T., Oelzner, P., Wolf, G., Freesmeyer, M., and Pfeil, A., Distribution patterns of arterial affection and the influence of glucocorticoids on 18F-fluorodeoxyglucose positron emission tomography\/CT in patients with giant cell arteritis, RMD Open, 2022, vol. 8, no. 2, p. e002464. https:\/\/doi.org\/10.1136\/rmdopen-2022-002464","DOI":"10.1136\/rmdopen-2022-002464"},{"key":"7541_CR44","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1002\/acr.24055","volume":"72","author":"K.B. Gribbons","year":"2020","unstructured":"Gribbons, K.B., Ponte, C., Carette, S., Craven, A., Cuthbertson, D., Hoffman, G.S., Khalidi, N.A., Koening, C.L., Langford, C.A., Maksimowicz-Mckinnon, K., Mcalear, C.A., Monach, P.A., Moreland, L.W., Pagnoux, Ch., Quinn, K.A., Robson, J.C., Seo, P., Sreih,\u00a0A.G., Suppiah, R., Warrington, K.J., Ytterberg,\u00a0S.R., Luqmani, R., Watts, R., Merkel, P.A., and Grayson, P.C., Patterns of arterial disease in takayasu arteritis and giant cell arteritis, Arthritis Care Res. (Hoboken), 2020, vol. 72, no. 11, pp. 1615\u20131624. https:\/\/doi.org\/10.1002\/acr.24055","journal-title":"Arthritis Care Res."},{"key":"7541_CR45","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1024\/0301-1526\/a000096","volume":"40","author":"S. F\u00f6rster","year":"2011","unstructured":"F\u00f6rster, S., Tato, F., Weiss, M., Czihal, M., Rominger, A., et al., Patterns of extracranial involvement in newly diagnosed giant cell arteritis assessed by physical examination, colour coded duplex sonography and FDG-PET, Vasa, 2011, vol. 40, no. 3, pp. 219\u2013227. https:\/\/doi.org\/10.1024\/0301-1526\/a000096","journal-title":"Vasa"},{"key":"7541_CR46","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s00259-018-4106-0","volume":"46","author":"B.D. Nielsen","year":"2019","unstructured":"Nielsen, B.D., Hansen, I.T., Kramer, S., Haraldsen,\u00a0A., Hjorthaug, K., Bogsrud, T.V., Ejlersen, J.A., Stolle, L.B., Keller, K.K., Therkildsen, P., Hauge, E.-M., and Gormsen, L.Ch., Simple dichotomous assessment of cranial artery inflammation by conventional 18F-FDG PET\/CT shows high accuracy for the diagnosis of giant cell arteritis: a case-control study, Eur. J. Nucl. Med. Mol. Imaging, 2019, vol. 46, no. 1, pp. 184\u2013193. https:\/\/doi.org\/10.1007\/s00259-018-4106-0","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"7541_CR47","doi-asserted-by":"publisher","unstructured":"Rottenburger, Ch., Mensch, N., Imfeld, S., Aschwanden, M., Glatz, K., Staub, D., Berger, Ch.T., and Daikeler, T., 18F-FDG PET\/CT compared with ultrasound and biopsy for detection of vasculitis of the temporal artery branches, Swiss Med. Wkly., 2021, vol. 151, no. 2324, p. w20512. https:\/\/doi.org\/10.4414\/smw.2021.20512","DOI":"10.4414\/smw.2021.20512"},{"key":"7541_CR48","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","volume":"79","author":"B. Hellmich","year":"2020","unstructured":"Hellmich, B., Agueda, A., Monti, S., Buttgereit, F., De Boysson, H., Brouwer, E., Cassie, R., Cid, M.C., Dasgupta, B., Dejaco, Ch., Hatemi, G., Hollinger, N., Mahr, A., Mollan, S.P., Mukhtyar, Ch., Ponte, C., Salvarani, C., Sivakumar, R., Tian, X., Tomasson, G., Turesson, C., Schmidt, W., Villiger, P.M., Watts, R., Young, Ch., and Luqmani, R.A., 2018 Update of the EULAR recommendations for the management of large vessel vasculitis, Ann. Rheum. Dis., 2020, vol. 79, no. 1, pp. 19\u201330. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215672","journal-title":"Ann. Rheum. Dis."},{"key":"7541_CR49","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/art.41774","volume":"73","author":"M. Maz","year":"2021","unstructured":"Maz, M., Chung, Sh.A., Abril, A., Langford, C.A., Gorelik, M., Guyatt, G., Archer, A.M., Conn, D.L., Full, K.A., Grayson, P.C., Ibarra, M.F., Imundo, L.F., Kim, S., Merkel, P.A., Rhee, R.L., Seo, P., Stone,\u00a0J.H., Sule, S., Sundel, R.P., Vitobaldi, O.I., Warner, A., Byram, K., Dua, A.B., Husainat, N., James, K.E., Kalot, M.A., Lin, Yi.Ch., Springer, J.M., Turgunbaev, M., Villa-forte, A., Turner, A.S., and Mustafa, R.A., 2021 American College of Rheumatology\/Vasculitis Foundation guideline for the management of giant cell arteritis and Takayasu arteritis, Arthritis Rheumatol., 2021, vol. 73, no. 8, pp. 1349\u20131365. https:\/\/doi.org\/10.1002\/art.41774","journal-title":"Arthritis Rheumatol."},{"key":"7541_CR50","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/nrrheum.2017.142","volume":"13","author":"Ch. Dejaco","year":"2017","unstructured":"Dejaco, Ch., Brouwer, E., Mason, J.C., Buttgereit, F., Matteson, E.L., and Dasgupta, B., Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities, Nat. Rev. Rheumatol., 2017, vol. 13, no.\u00a010, pp. 578\u2013592. https:\/\/doi.org\/10.1038\/nrrheum.2017.142","journal-title":"Nat. Rev. Rheumatol."},{"key":"7541_CR51","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.3899\/jrheum.141347","volume":"42","author":"T.A. Kermani","year":"2015","unstructured":"Kermani, T.A., Warrington, K.J., Cuthbertson, D., Carette, S., Hoffman, G.S., Khalidi, N.A., Koening,\u00a0C.L., Langford, C.A., Maksimowicz-Mckinnon, K., Mcalear, C.A., Monach, P.A., Seo, P., Merkel, P.A., and Ytterberg, S.R., Disease relapses among patients with giant cell arteritis: a prospective, longitudinal cohort study, J. Rheumatol., 2015, vol. 42, no. 7, pp. 1213\u20131217. https:\/\/doi.org\/10.3899\/jrheum.141347","journal-title":"J. Rheumatol."},{"key":"7541_CR52","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/ard-2022-223429","volume":"83","author":"C. Dejaco","year":"2024","unstructured":"Dejaco, C., Kerschbaumer, A., Aletaha, D., Bond, M., Hysa, E., et al., Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica, Ann. Rheum. Dis., 2024, vol. 83, no. 1, pp. 48\u201357. https:\/\/doi.org\/10.1136\/ard-2022-223429","journal-title":"Ann. Rheum. Dis."},{"key":"7541_CR53","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.semarthrit.2023.152192","volume":"60","author":"A. Lavergne","year":"2023","unstructured":"Lavergne, A., Dumont, A., Deshayes, S., Boutemy, J., Maign\u00e9, G., Silva, N.M., Nguyen, A., Gallou, S., Philip, R., Aouba, A., and De Boysson, H., Efficacy and tolerance of methotrexate in a real-life monocentric cohort of patients with giant cell arteritis, Semin. Arthritis Rheum., 2023, vol. 60, pp. 152\u2013192. https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152192","journal-title":"Semin. Arthritis Rheum."},{"key":"7541_CR54","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3899\/jrheum.181127","volume":"47","author":"A. Dumont","year":"2020","unstructured":"Dumont, A., Parienti, J.-J., Delmas, C., Boutemy, J., Maign\u00e9, G., Martin Silva, N., Sultan, A., Planchard, G., Aouba, A., and De Boysson, H., Factors associated with relapse and dependence on glucocorticoids in giant cell arteritis, J. Rheumatol., 2020, vol. 47, no. 1, pp.\u00a0108\u2013116. https:\/\/doi.org\/10.3899\/jrheum.181127","journal-title":"J. Rheumatol."},{"key":"7541_CR55","doi-asserted-by":"publisher","unstructured":"Vautier, M., Dupont, A., De Boysson, H., Comarmond, Ch., Mirault, T., Mekinian, A., Lambert, M., Ferfar, Ya., Aouba, A., Cacoub, P., Resche-Rigon, M., and Saadoun, D., Prognosis of large vessel involvement in large vessel vasculitis, J. Autoimmun., 2020, vol. 108, p. 102419. https:\/\/doi.org\/10.1016\/j.jaut.2020.102419","DOI":"10.1016\/j.jaut.2020.102419"},{"key":"7541_CR56","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/acr.22942","volume":"69","author":"M. Catanoso","year":"2017","unstructured":"Catanoso, M., Macchioni, P., Boiardi, L., Muratore, F., Restuccia, G., Cavazza, A., Pipitone, N., Mancuso, P., Luberto, F., and Salvarani, C., Incidence, prevalence, and survival of biopsy-proven giant cell arteritis in Northern Italy during a 26-year period, Arthritis Care Res., 2017, vol. 69, no. 3, pp. 430\u2013438. https:\/\/doi.org\/10.1002\/acr.22942","journal-title":"Arthritis Care Res."},{"key":"7541_CR57","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/rheumatology\/key285","volume":"58","author":"T. Garen","year":"2018","unstructured":"Garen, T., Lerang, K., Hoffmann-Vold, A.-M., Andersson, H., Midtvedt, \u00d8., Brunborg, C., Kilian, K., Gudbrandsson, B., Gunnarsson, R., Norby, G., Chaudhary, A., Thoen, J., Forseth, K.\u00d8., Fresjar, K., F\u00f8rre, \u00d8., Haugen, M., Haga, H.-J., Gran, J.T., Gilboe, I.-M., Molberg, \u00d8., and Palm, \u00d8., Mortality and causes of death across the systemic connective tissue diseases and the primary systemic vasculitides, Rheumatology, 2018, vol. 58, no. 2, pp. 313\u2013320. https:\/\/doi.org\/10.1093\/rheumatology\/key285","journal-title":"Rheumatology"},{"key":"7541_CR58","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.semarthrit.2016.08.015","volume":"46","author":"C.L. Hill","year":"2017","unstructured":"Hill, C.L., Black, R.J., Nossent, J.C., Ruediger, C., Nguyen, L., Ninan, J.V., and Lester, S., Risk of mortality in patients with giant cell arteritis: a systematic review and meta-analysis, Semin. Arthritis Rheum., 2017, vol. 46, no. 4, pp. 513\u2013519. https:\/\/doi.org\/10.1016\/j.semarthrit.2016.08.015","journal-title":"Semin. Arthritis Rheum."}],"container-title":["Doklady Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S1607672924700984.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1134\/S1607672924700984","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S1607672924700984.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T15:21:59Z","timestamp":1773760919000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1134\/S1607672924700984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,13]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["7541"],"URL":"https:\/\/doi.org\/10.1134\/s1607672924700984","relation":{},"ISSN":["1607-6729","1608-3091"],"issn-type":[{"value":"1607-6729","type":"print"},{"value":"1608-3091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,13]]},"assertion":[{"value":"11 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors of this work declare that they have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"CONFLICT OF INTEREST"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. The study was approved by the local ethical committee of the Sechenov First Moscow State Medical University of the Russian Ministry of Health (Sechenov University) (protocol no. 01-21 of January 22, 2021). All patients signed written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"ETHICS APPROVAL AND CONSENT TO PARTICIPATE"}}]}}